Immunogenicity 13542
Sample ID
3998
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ZFP62
Transcript ID
uc021yjo.1
HLA INFO
B*18:01
TCR INFO
No TCR info found!
Full length protein sequence (867 aa)
MPESK
1
VGDTC
6
VWDSK
11
VENQQ
16
KKPVE
21
NRMKE
26
DKSSI
31
REAIS
36
KAKST
41
ANIKT
46
EQEGE
51
ASEKS
56
LHLSP
61
QHITH
66
QTMPI
71
GQRGS
76
EQGKR
81
VENIN
86
GTSYP
91
SLQQK
96
TNAVK
101
KLHKC
106
DECGK
111
SFKYN
116
SRLVQ
121
HKIMH
126
TGEKR
131
YECDD
136
CGGTF
141
RSSSS
146
LRVHK
151
RIHTG
156
EKPYK
161
CEECG
166
KAYMS
171
YSSLI
176
NHKST
181
HSGEK
186
NCKCD
191
ECGKS
196
FNYSS
201
VLDQH
206
KRIHT
211
GEKPY
216
ECGEC
221
GKAFR
226
NSSGL
231
RVHKR
236
IHTGE
241
KPYEC
246
DICGK
251
TFSNS
256
SGLRV
261
HKRIH
266
TGEKP
271
YECDE
276
CGKAF
281
ITCRT
286
LLNHK
291
SIHFG
296
DKPYK
301
CDECE
306
KSFNY
311
SSLLI
316
QHKVI
321
HTGEK
326
PYECD
331
ECGKA
336
FRNSS
341
GLIVH
346
KRIHT
351
GEKPY
356
KCDVC
361
GKAFS
366
YSSGL
371
AVHKS
376
IHPGK
381
KAHEC
386
KECGK
391
SFSYN
396
SLLLQ
401
HRTIH
406
TGERP
411
YVCDV
416
CGKTF
421
RNNAG
426
LKVHR
431
RLHTG
436
EKPYK
441
CDVCG
446
KAYIS
451
RSSLK
456
NHKGI
461
HLGEK
466
PYKCS
471
YCEKS
476
FNYSS
481
ALEQH
486
KRIHT
491
REKPF
496
GCDEC
501
GKAFR
506
NNSGL
511
KVHKR
516
IHTGE
521
RPYKC
526
EECGK
531
AYISL
536
SSLIN
541
HKSVH
546
PGEKP
551
FKCDE
556
CEKAF
561
ITYRT
566
LTNHK
571
KVHLG
576
EKPYK
581
CDVCE
586
KSFNY
591
TSLLS
596
QHRRV
601
HTREK
606
PYECD
611
RCEKV
616
FRNNS
621
SLKVH
626
KRIHT
631
GERPY
636
ECDVC
641
GKAYI
646
SHSSL
651
INHKS
656
THPGR
661
TPHTC
666
DECGK
671
AFFSS
676
RTLIS
681
HKRVH
686
LGEKP
691
FKCVE
696
CGKSF
701
SYSSL
706
LSQHK
711
RIHTG
716
EKPYV
721
CDRCG
726
KAFRN
731
SSGLT
736
VHKRI
741
HTGEK
746
PYECD
751
ECGKA
756
YISHS
761
SLINH
766
KSVHQ
771
GKQPY
776
NCECG
781
KSFNY
786
RSVLD
791
QHKRI
796
HTGKK
801
PYRCN
806
ECGKA
811
FNIRS
816
NLTKH
821
KRTHT
826
GEESL
831
NVIYV
836
GSYSG
841
TSQKR
846
TYEGG
851
NALDG
856
GRMRM
861
PL
866
Mutation Information
DNA mutation:
None
Peptide Range:
782 ~ 806
Mut AA position:
794 (13 in Wild Type peptide)
Alignment
Wild Type:
"CECGKSFNYRSVLDQHKRIHTGKKP
||||||||||||.||||||||||||
Mutant:
CECGKSFNYRSVFDQHKRIHTGKKP"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) ZFP62
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
COS7
Assay
IFNg ELISPOT assay